Sign in

CIK 0001623526

  • Non-accelerated filer
  • Smaller reporting company

Stoke Therapeutics, Inc.

Sign in to watch
Ticker
STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
471144582
Phone
+1 781-430-8200
Business address
45 WIGGINS AVENUE, BEDFORD, MA, 01730
Former names
ASOthera Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$403,975
in 4 filings, $404K under 10b5-1 plans

Net −$403,975. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-07-07 Nash Huw M. COO & CBO Sale −913 $22.41 $20K 0
2020-07-01 Nash Huw M. COO & CBO Exercise or conversion +3,800 $2.19 $8K 3,800
2020-07-01 Nash Huw M. COO & CBO Sale −3,800 $23.15 $88K 0
2020-07-01 Nash Huw M. COO & CBO Exercise or conversion · Employee Stock Option (Right to Buy) −3,800 224,911
2020-06-03 TZIANABOS ARTHUR Director Grant or award · Director Stock Option (Right to Buy) +14,777 14,777
2020-06-03 Smith Julie Director Grant or award · Director Stock Option (Right to Buy) +29,555 29,555
2020-06-03 LEVIN ARTHUR A Director Grant or award · Director Stock Option (Right to Buy) +14,777 14,777
2020-06-03 Krainer Adrian R. Director Grant or award · Director Stock Option (Right to Buy) +14,777 14,777
2020-06-03 Harrison Seth Loring Director Grant or award · Director Stock Option (Right to Buy) +14,777 14,777
2020-06-03 Burstein Jennifer Director Grant or award · Director Stock Option (Right to Buy) +14,777 14,777
2020-06-01 Ticho Barry Chief Medical Officer Exercise or conversion +131,147 $0.60 $79K 131,147
2020-06-01 Ticho Barry Chief Medical Officer Exercise or conversion +42,880 $2.19 $94K 174,027
2020-06-01 Ticho Barry Chief Medical Officer Sale −1,000 $27.17 $27K 173,027
2020-06-01 Ticho Barry Chief Medical Officer Sale −365 $27.98 $10K 172,662
2020-06-01 Ticho Barry Chief Medical Officer Exercise or conversion · Employee Stock Option (Right to Buy) −131,147 85,946
2020-06-01 Ticho Barry Chief Medical Officer Exercise or conversion · Employee Stock Option (Right to Buy) −42,880 85,765
2020-06-01 Liau Gene EVP Research & Preclinical Dev Exercise or conversion +20,000 $2.19 $44K 33,500
2020-06-01 Liau Gene EVP Research & Preclinical Dev Sale −10,895 $25.82 $281K 22,605
2020-06-01 Liau Gene EVP Research & Preclinical Dev Sale −7,875 $26.91 $212K 14,730
2020-06-01 Liau Gene EVP Research & Preclinical Dev Sale −1,230 $27.48 $34K 13,500

Page 31 of 35 · 681 trades